Pharma Mar, S.A. (BME:PHM)
Spain · Delayed Price · Currency is EUR 74.75
+0.10 (0.13%)
Dec 10, 2025, 3:50 PM CET
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of €1.28 billion as of December 10, 2025. Its market cap has decreased by -5.49% in one year.
Market Cap
1.28B
Enterprise Value
1.19B
Revenue
179.28M
Ranking
n/a
PE Ratio
38.27
Stock Price
€74.75
Market Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.80B to 1.28B, a decrease of -28.59%. That is a compound annual growth rate of -3.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 1.28B | -7.51% |
| Dec 31, 2024 | 1.39B | 88.09% |
| Dec 29, 2023 | 738.49M | -36.23% |
| Dec 30, 2022 | 1.16B | 12.13% |
| Dec 30, 2021 | 1.03B | -21.36% |
| Dec 31, 2020 | 1.31B | 66.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.53B |
| Laboratorios Farmaceuticos Rovi | 3.06B |
| Almirall | 2.78B |
| Faes Farma | 1.46B |
| Clínica Baviera | 760.57M |
| Oryzon Genomics | 252.33M |
| Prim, S.A. | 235.67M |
| Laboratorio Reig Jofre | 227.89M |